Macular Edema

Showing NaN - NaN of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Branch Retinal Vein Occlusion
  • Phoenix, Arizona
  • +151 more
Aug 4, 2022

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting
  • Macular Edema
  • +2 more
  • Mesa, Arizona
  • +193 more
Jul 25, 2022

Uveitis, Macular Edema Trial in Worldwide (Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg,

Completed
  • Uveitis
  • Macular Edema
  • Dexamethasone intravitreal implant 0.7 mg
  • +2 more
  • Los Angeles, California
  • +32 more
Mar 31, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Peoria, Arizona
  • +109 more
Mar 18, 2021

Macular Edema Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Edema
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Graz, Steiermark, Austria
  • +63 more
Jul 15, 2020

Diabetes, Diabetic Retinopathy, Macular Edema Trial in Worldwide (Ranibizumab 0.5mg, THR-317 8mg, Sham injection)

Completed
  • Diabetes Mellitus
  • +2 more
  • Ranibizumab 0.5mg
  • +2 more
  • Brussels, Belgium
  • +36 more
Aug 1, 2019

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (700 µg Dexamethasone, 350 µg Dexamethasone, Sham Injection)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • 700 µg Dexamethasone
  • +2 more
  • Houston, Texas
  • +12 more
Apr 11, 2019

Retinal Vein Occlusion, Macular Edema Trial in Worldwide (dexamethasone intravitreal implant, ranibizumab)

Completed
  • Retinal Vein Occlusion
  • Macular Edema
  • dexamethasone intravitreal implant
  • ranibizumab
  • Paris, France
  • +5 more
Apr 9, 2019

Macular Edema Trial in Worldwide (dexamethasone Intravitreal Implant, ranibizumab)

Completed
  • Macular Edema
  • Arlington, Texas
  • +12 more
Apr 9, 2019

Macular Edema Trial in Worldwide (BI 1026706, Placebo)

Completed
  • Macular Edema
  • BI 1026706
  • Placebo
  • Brussel, Belgium
  • +34 more
Mar 18, 2019

Macular Edema, Uveitis Trial in Worldwide (Periocular triamcinolone 40 mg, Intravitreal triamcinolone 4 mg, Dexamethasone

Completed
  • Macular Edema
  • Uveitis
  • Periocular triamcinolone 40 mg
  • +2 more
  • Los Angeles, California
  • +25 more
Nov 6, 2018

Macular Edema Trial in Worldwide (Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Edema
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Graz, Steiermark, Austria
  • +75 more
Sep 12, 2018

Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab 0.5 mg/0.05 ml)

Completed
  • Macular Edema
  • Central Retinal Vein Occlusion
  • Ranibizumab 0.5 mg/0.05 ml
  • Parramatta, New South Wales, Australia
  • +77 more
Sep 21, 2016

Visual Impairment, Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab, Dexamethasone implant and sham

Completed
  • Visual Impairment
  • +2 more
  • Augsburg, Germany
  • +63 more
Sep 21, 2016

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (AGN208397 intravitreal injection, dexamethasone intravitreal implant)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • AGN208397 intravitreal injection
  • dexamethasone intravitreal implant
  • Phoenix, Arizona
  • +4 more
Mar 27, 2014